학술논문

Atezolizumab Plus Bevacizumab Combined with Transarterial Embolization Plus Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with a Diameter >8 Cm: A Retrospective Study.
Document Type
Article
Source
Journal of Hepatocellular Carcinoma; Feb2024, Vol. 11, p399-409, 11p
Subject
HEPATOCELLULAR carcinoma
ATEZOLIZUMAB
BEVACIZUMAB
CANCER chemotherapy
IMMUNE checkpoint inhibitors
Language
Abstract
Copyright of Journal of Hepatocellular Carcinoma is the property of Dove Medical Press Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Online Access